new biotech drug for rheumatoid arthritis called Orencia (oh-REN-see-ah)
February 2006
You'll see a new biotech drug for rheumatoid arthritis called Orencia (oh-REN-see-ah).
Orencia (abatacept) is an immune modulator. It inhibits T-cell activation...but it works "upstream" from where TNF blockers work.
This means that Orencia reduces the production of tumor necrosis factor plus other immune modulators. But it's not known if this mechanism improves efficacy.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote